Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 02, 2024 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,813 | -- | 23,894 |
Feb 03, 2023 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,726 | -- | 14,408 |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,749 | -- | -- |
Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | -- | -- |
Feb 01, 2019 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,716 | -- | 12,921 |
Feb 03, 2017 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,425 | -- | 11,031 |
Jun 01, 2015 |
SVP and CFO
|
SVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,538 | -- | -- |
Feb 03, 2015 |
SVP and CFO
|
SVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,429 | -- | 5,567 |
Feb 01, 2013 |
SVP and CFO
|
SVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,047 | -- | 8,047 |
Aug 21, 2012 |
SVP and CFO
|
SVP and CFO | Form 4 | Conversion of derivative security | 1,087 | -- | 1,225 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.